Supernus Pharmaceuticals Inc (SUPN)
Net Income Growth
-359.44%
Quarterly · Period ending:
SUPN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-359.44%period ending
Latest reported-359.44%period ending
SUPN Quarterly Net Income YoY % (-4.68% → -359.44%)
Year-over-year change
High-resolution chart · PNG
SUPN net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -359.4382% | |
| 80.6122% | |
| -126.7811% | |
| -217.1961% | |
| 12.9695% | |
| -9,637.9032% | |
| 1,204.5106% | |
| 340.9677% | |
| 2,496.6306% | |
| -99.2684% | |
| -95.3887% | |
| -1,013.4362% | |
| -110.5658% | |
| -33.8382% | |
| 943.448% | |
| -91.8885% | |
| -66.8507% | |
| 349.8771% | |
| -92.0632% | |
| -46.091% | |
| -31.5603% | |
| -73.5384% | |
| -7.1267% | |
| 38.5897% | |
| 5.9278% | |
| 17.3282% | |
| 27.9458% | |
| 3.031% | |
| 6.4743% | |
| -30.4038% | |
| 89.5812% | |
| 75.4965% | |
| 76.9749% | |
| 155.9192% | |
| -4.6162% | |
| -74.184% | |
| 69.4274% | |
| 113.4093% | |
| 108.3976% | |
| 1,478.8049% | |
| 320.6401% | |
| 553.794% | |
| 57.7727% | |
| -85.943% | |
| -23.8913% | |
| 104.7481% | |
| 119.4368% | |
| 215.6125% | |
| 111.7045% | |
| 15.5914% | |
| -65.823% | |
| -78.7272% | |
| -173.2148% | |
| -98.4909% | |
| -116.4809% | |
| -38.5042% | |
| -35.7327% | |
| 16.0377% | |
| 1,056.3899% | |
| -4.6841% |